Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Nature Communications|April 2, 2026
Semi-transparent and eco-friendly face masks for PM0.3 filtration via biomimetic-fractal nanofibersZungui Shao, Yongkui Liu, Shikang Huo, et al.
Cancers|December 23, 2022
Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM PatientsXiaoyan Yue, Donghua He, Gaofeng Zheng, et al.
Frontiers in Oncology|July 26, 2021
Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple MyelomaJingSong He, XiaoYan Yue, DongHua He, et al.
Quantitative Imaging in Medicine and Surgery|June 3, 2022
Current development and prospects of deep learning in spine image analysis: a literature reviewBiao Qu, Jianpeng Cao, Chen Qian, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 8, 2022
The efficacy of residual plerixafor for second-day stem cell mobilization in multiple myeloma patientsDonghua He, Chunting Zhu, Xing Guo, et al.
Frontiers in Oncology|July 1, 2021
Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Date in ChinaXiaoyan Han, Chunxiang Jin, Gaofeng Zheng, et al.
Frontiers in Oncology|September 20, 2021
Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in ChinaXiaoyan Han, Chunxiang Jin, Gaofeng Zheng, et al.
Frontiers in Pharmacology|December 28, 2020
Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World DataJingsong He, Donghua He, Xiaoyan Han, et al.
Cancer Medicine|May 3, 2024
Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in ChinaXiaoyan Han, Xincheng Jiang, Jingsong He, et al.
Cancer Biology & Therapy|September 19, 2024
The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patientsLinlin Huang, Yi Zhong, Qingxiao Chen, et al.
Pageof 11